Together with our thyroid partners, we ran a survey in November 2019 to look into the prescribing practices of CCGs across England since the NHS England guidance was published – the T3 Prescribing Survey 2019. … T3 Prescribing Survey
We are working hard to ensure that patients can access the thyroid medication they need such as liothyronine, hence our #T3Campaign. If you want to find out more about our #T3Campaign, you can find all… Our #T3Campaign
Thyroid UK and other thyroid groups have been working with RMOC to clarify the guidance they published last November. We all felt that their guidance was not clear enough for CCGs and clinicians in respect… We are working with RMOC to clarify the guidance they published in November 2018
You may be aware that a coalition of thyroid organisations, including the British Thyroid Association (BTA), worked together on a Dossier for the Lord O’Shaughnessy in respect of the harm being done to patients in… Article in RMOC newsletter
Thyroid UK, along with other thyroid groups including the British Thyroid Association, has worked on a dossier that was requested by the Lord O’Shaughnessy, the Parliamentary Under-Secretary of State for Health and Social Care. He wanted to… Lord O’Shaugnessy Dossier
The dossier of evidence requested in the Regret Debate led by Lord Hunt in respect of liothyronine has been worked on for many weeks by Thyroid UK, The Thyroid Trust, Improve Thyroid Treatment Campaign Group,… The dossier has been sent to Lord O’Shaugnessy
A very good meeting was held at the House of Commons with Thyroid Trust, ITT, Midlands Thyroid Support, Norfolk Thyroid Group, TPA, BTF and BTA. It was agreed that we would all work on a… Loose coalition forms to gather evidence for Lord O’Shaugnessy
As you may know, Lord Hunt of Kings Heath led a regret debate in the House of Lords on Wednesday 20th June, which went really well. What you may not know is that the person who… The Regret debate in The House of Lords
Lord Hunt of Kings Heath has secured a Motion to regret – Branded Health Service Medicines (Costs) Regulations 2018 on Wednesday 20th June in the House of Lords at around 7pm. The actual Motion is: Lord Hunt… Lord Hunt secures debate in The House of Lords
Thyroid UK and ITT travelled to London yesterday to meet with NHS England and NHS Clinical Commissioning to voice our concerns about T3. The meeting was attended by Julie Woods, CEO of Clinical Commissioning and… Meeting with NHS England and NHS Clinical Commissioning
An adjournment debate has been tabled by Vince Cable MP, Leader of the Liberal Democrats for Monday 21st May at 2.30pm, so we have designed a template email that is shorter than the other one… Parliamentary debate on hypothyroidism
We need your help! Please contact your MP We are pleased to announce that Thyroid UK has been working with ITT (Improve Thyroid Health) and TPA (Thyroid Patient Advocacy) on a joint report entitledImproving T3… Improving T3 Prescription in the UK – a Joint Campaign on behalf of Thyroid Patients
NHS England gave its decision at a board meeting this morning about whether liothyronine will be deprescribed by the NHS. Read a transcript of the meeting Liothyronine Of those respondents who either agreed or disagreed with… NHS Board decides on the question of deprescribing T3